{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:53:51Z","timestamp":1789401231213,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T00:00:00Z","timestamp":1442966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.semarthrit.2015.06.016","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T10:17:48Z","timestamp":1435313868000},"page":"351-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Pregnancy outcomes following exposure to abatacept during pregnancy"],"prefix":"10.1016","volume":"45","author":[{"given":"Monica","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2015.06.016_bib1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.contraception.2011.07.013","article-title":"Unintended pregnancy in the United States: incidence and disparities, 2006","volume":"84","author":"Finer","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib3","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/BOR.0000000000000046","article-title":"Rheumatoid arthritis and pregnancy: impediments to optimal management of both biologic use before, during and after pregnancy","volume":"26","author":"Williams","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib5","first-page":"1","article-title":"ACR reproductive health summit on the management of pregnant and lactating women with autoimmune diseases","volume":"5","author":"Dao","year":"2014","journal-title":"Drug Saf Q"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib6","first-page":"1","article-title":"Drug safety during pregnancy in the rheumatoid patient: top ten considerations","volume":"4","author":"Cush","year":"2013","journal-title":"Drug Saf Q"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib7","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/rheumatology\/ket409","article-title":"Biologic therapies and pregnancy: the story so far","volume":"53","author":"Hyrich","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib8","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2165\/11596240-000000000-00000","article-title":"Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management","volume":"71","author":"Makol","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib9","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/rheumatology\/ker302","article-title":"Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use","volume":"50","author":"Hazes","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib10","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/art.30206","article-title":"Rheumatoid arthritis and pregnancy: beyond smaller and preterm babies","volume":"63","author":"Chakravarty","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib11","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/art.24914","article-title":"Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study","volume":"60","author":"de Man","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/BOR.0000000000000061","article-title":"Pregnancy and rheumatoid arthritis\u2014do not let the perfect become the enemy of the good","volume":"26","author":"Cush","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib13","unstructured":"Food and Drug Administration. Pregnancy and lactation labeling, 2014, \u3008http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/Labeling\/ucm093307.htm\u3009; [accessed 30.01.15]."},{"key":"10.1016\/j.semarthrit.2015.06.016_bib14","unstructured":"Food and Drug Administration. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling, \u3008https:\/\/federalregister.gov\/a\/2014-28241\u3009; [accessed 30.01.15]."},{"key":"10.1016\/j.semarthrit.2015.06.016_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1759720X14551568","article-title":"Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know","volume":"6","author":"Krause","year":"2014","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/BOR.0000000000000054","article-title":"Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy","volume":"26","author":"Bermas","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl. 3","key":"10.1016\/j.semarthrit.2015.06.016_bib17","first-page":"iii28","article-title":"Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs","volume":"47","author":"Ostensen","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/sj.jp.7211631","article-title":"Neonatal anemia and hydrops fetalis after maternal mycophenolate mofetil use","volume":"27","author":"Tjeertes","year":"2007","journal-title":"J Perinatol"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib19","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/01.tp.0000252683.74584.29","article-title":"Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus","volume":"82","author":"Sifontis","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/acr.20422","article-title":"Patterns of medication use during pregnancy in rheumatoid arthritis","volume":"63","author":"Kuriya","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.reprotox.2011.05.009","article-title":"Safety of infliximab use during pregnancy","volume":"32","author":"Djokanovic","year":"2011","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00393-010-0640-2","article-title":"Biologics during pregnancy and breast-feeding","volume":"69","author":"Fischer-Betz","year":"2010","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib23","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.3748\/wjg.v19.i17.2591","article-title":"Tumor necrosis factor-\u03b1 inhibitor therapy and fetal risk: a systemic literature review","volume":"19","author":"Marchioni","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10067-012-2156-4","article-title":"Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases","volume":"32","author":"Ojeda-Uribe","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib26","unstructured":"Bristol-Myers Squibb. Orencia prescribing information, \u3008http:\/\/packageinserts.bms.com\/pi\/pi_orencia.pdf\u3009; [accessed 30.01.15]."},{"key":"10.1016\/j.semarthrit.2015.06.016_bib27","article-title":"Fertility in women with rheumatoid arthritis: influence of disease activity and medication","author":"Brouwer","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib28","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/art.38874","article-title":"Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study","volume":"66","author":"Rom","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib29","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/art.38519","article-title":"Rheumatoid arthritis during pregnancy and postnatal catch-up growth in the offspring","volume":"66","author":"de Steenwinkel","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib30","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.38368","article-title":"Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study","volume":"66","author":"Weber-Schoendorfer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib31","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2010.140822","article-title":"Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register","volume":"70","author":"Verstappen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198807283190401","article-title":"Incidence of early loss of pregnancy","volume":"319","author":"Wilcox","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/(SICI)1096-9926(200004)61:4<314::AID-TERA11>3.0.CO;2-7","article-title":"Mini-review: history of organized teratology information services in North America","volume":"61","author":"Leen-Mitchell","year":"2000","journal-title":"Teratology"},{"key":"10.1016\/j.semarthrit.2015.06.016_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/BOR.0000000000000044","article-title":"Contraception and pregnancy counselling in rheumatoid arthritis","volume":"26","author":"Ostensen","year":"2014","journal-title":"Curr Opin Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215001821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215001821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T04:50:31Z","timestamp":1620795031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017215001821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0049017215001821"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.016","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy outcomes following exposure to abatacept during pregnancy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}